Bain Capital Public Equity LP

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Bain Capital Public Equity LP
CRD #145650
SEC #801-69070
CIK #0001962552, 0001156175
AUM 242.2 M (2026-03-31)
Employees 26 (15% Investors, 0% Brokers)
Fees
Minimum
Phone617-516-2318
Address200 Clarendon Street
Boston, MA 02116
Source [IAPD] [EDGAR] [Website] [Twitter] [LinkedIn]
Total AUM ($B)
151296302007201320202027
Fees and Compensation — Form ADV Part 2A (3/31/2026) [Brochure]
Item 5. Fees and Compensation

Fees

As compensation for investment advisory services rendered to the Public Equity Clients, Bain
Capital Public Equity receives from applicable Public Equity Clients an annual management fee
payable quarterly in advance. Certain vehicles also pay management fees on a monthly basis.
Personnel of Bain Capital Public Equity and its affiliates are largely exempt from paying
management fees. Upon the termination of an Advisory Agreement, appropriate treatment,
including, where applicable, returning prepaid management fees on a prorated basis, will be
given to all fees collected in advance. Management fees paid by a Public Equity Client are
indirectly borne by the investors in such Public Equity Client.

The precise amount of, and the manner and calculation of, the management fee for each Public
Equity Fund is established by Bain Capital Public Equity and set forth in such Public Equity ’s
Advisory Agreement, governing documents and/or other documentation received by each
investor prior to investment in such Public Equity Fund. The fee structures described above may
be modified from time to time.

Fees differ from one Public Equity Client to another, as well as among investors in the same
Public Equity Client. In its sole discretion, Bain Capital Public Equity may waive or reduce
management fees, including for certain investors.

Expenses

The Public Equity Clients generally bear their own expenses. These expenses may vary among
Public Equity Clients and are subject to the terms and conditions set forth in the applicable Public
Equity Client’s offering materials, governing documents, or other analogous organizational

documents. The expenses generally borne by Public Equity Funds are outlined below.

Unless otherwise specified herein or in such Public Equity Fund’s organizational documents, each
eligible Public Equity Fund bears its organizational, operational, and offering expenses and
obligations (which include):

  (a) all out-of-pocket expenses incurred in connection with organizing and establishing the
      Public Equity Fund and the General Partner, offering interests in the Public Equity Fund
      (including legal and accounting expenses, filing fees and expenses, travel,
      accommodation and related expenses, printing costs or any other expenses incurred with
      respect to the offering) (“Organizational Expenses”);

  (b) all investment-related expenses (including any such expenses incurred in connection with
      potential investments, whether or not completed), including: expenses relating to
       identifying, discovering, sourcing, developing (including any retainers, success and
       finder’s fees and other compensation paid to contractors, senior advisers and sourcing
       and operating partners), evaluating, valuing, researching, investigating, structuring
       (including rating agency fees and expenses), diligencing, monitoring, maintaining,
       purchasing, making, holding, acquiring, registering (including notary and “gestoria” costs),
       selling (or potentially selling), or restructuring investments (whether or not completed,
       including broken deal and reverse break-up fees, liquidated damages, forfeited deposits,
       reverse termination fees or similar payments); all lodging, travel, transportation (including
       the use of charter, first class or business travel and taxis and car rentals and any other
       transportation), meals, and related expenses (including any of these incurred by an
       investment team or other member of the General Partner or Bain Capital Public Equity or
       their affiliates) incurred in connection with the Public Equity Funds’ affairs, and with
       evaluating, making and monitoring investments; professional costs and expenses
       (including legal, compliance, tax, financial, accounting, actuarial, valuation, advisory and
       consulting/experts (including consultants or experts for industry-specific matters, due
       diligence, reference checks, sourcing or introductions and other similar costs)); brokerage
       commissions, hedging costs, expenses relating to short sales, prime brokerage fees,
       financing costs and expenses, custodial expenses, clearing and settlement charges,
       private placement fees, syndication fees, solicitation fees, arranger fees, sales
       commissions, pricing and valuation fees (including appraisal fees), underwriting
       commissions and discounts, investment banking fees, advisory fees (including income-
       based repayments, receivership costs and similar fees and costs), and bank charges, and
       custodial, trustee, transfer agent, recordkeeping and other administrative costs; fees of
       third- party experts or consultants; and value-added taxes and taxes incurred in
       connection with investments;

  (c) all expenses of the Public Equity Funds incurred in connection with the ongoing operation

      and administration of the Public Equity Funds, including: any legal, tax, auditing,
      accounting and consulting fees, bookkeeping, record keeping, environmental, social, and
      governance (“ESG”), procurement, cybersecurity, and clerical services to the Public Equity
      Funds;

(d) fees, taxes and expenses associated with the Public Equity Funds’ audits and financial
    statements (including fees and expenses associated with preparing tax information,
    returns and elections), including fees and expenses associated with preparing, filing or
    distributing tax information, returns or elections and complying with any tax audit,
    investigation, settlement or review; expenses incurred in connection with the preparation
    and maintenance of the Public Equity Funds’ books and records and account holder
    diligence; expenses incurred in connection with the preparation and delivery of wires and
    distributions, financial and other reports, circulars, forms, notices, valuations, investment
...
Account Minimums and Types of Clients — Form ADV Part 2A (3/31/2026) [Brochure]
Item 7. Types of Clients

Bain Capital Public Equity currently provides investment advisory services to the Public Equity
Funds. Investment advice is provided directly to the Public Equity Funds, subject to the direction
and control of the General Partner of such Public Equity Fund, and not individually to the Limited
Partners of such Public Equity Fund. As noted, Bain Capital Public Equity also sub-advises a
UCITs.

Except for the UCITS and BCEOF, interests in the Public Equity Funds are offered pursuant to

applicable exemptions from registration under the Securities Act and the 1940 Act. Investors in
the Public Equity Funds include high net worth individuals, banks, thrift institutions, pension and
profit sharing plans, trusts, estates, charitable organizations, university endowments,
corporations, limited partnerships and limited liability companies or other business entities.

Bain Capital Public Equity does not impose minimum dollar values on creating a Public Equity
Fund; however legal eligibility requirements must be met and minimum investment commitments
may be established for Limited Partners in the Public Equity Funds. The General Partner of each
Public Equity Fund, in its sole discretion, may permit investments below the required minimum
investment commitments.
CIK Period
0001962552 0001156175
Sector Form 13F Holdings Value ($B)
Alcoa Inc 0.0
Taiwan Semiconductor Manufacturing Co Ltd 0.0
Amazon Com Inc 0.0
Apple Inc 0.0
Performance Food Group Co 0.0
Hubbell Inc 0.0
Banco Santander Sa 0.0
Netflix Inc 0.0
Live Nation Entertainment Inc 0.0
Burlington Stores Inc 0.0
Morgan Stanley 0.0
Schwab Charles Corp 0.0
KKR & Co LP 0.0
Medline Inc 0.0
Crane Co 0.0
Citigroup Inc 0.0
Liberty Media Corp 0.0
Prudential PLC 0.0
Parker Hannifin Corp 0.0
Johnson & Johnson 0.0
 
 
 
 
 
 
 
 
 
 
 
Prev | Page 1 | Next
Type Form D Funds Date Sold AUM
HF Bain Capital Public Equity Enduring Equity Fund LP [2023-02-17] 455.0 M 575.0 M
Filed 2025-11-17 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
Other Bain Capital Public Equity Coinvest IV LP 2022-02-16 21.4 M
Other Bain Capital Public Equity Coinvest III LP 2020-07-07 27.6 M
Other Bain Capital Public Equity Coinvest II LP 2020-07-07 1.1 M
HF Bain Capital Public Equity Global Long Equity Fund LP 2020-02-21 1,184.6 M
Other Bain Capital Public Equity Coinvest Docusign LP 2018-03-30 27.6 M
HF Bain Capital Public Equity Global Partners Fund LP [2017-09-29] 514.7 M 155.9 M
Filed 2025-10-15 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF Bain Capital Public Equity Global Industrials Fund LP [2017-07-12] 209.7 M 255.1 M
Filed 2019-05-31 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF Brookside Capital Partners Fund III LP 2015-02-26 134.2 M
HF Brookside Capital Partners Fund II LP [2012-03-30] 975.5 M 112.6 M
Filed 2017-02-23 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
View All
AUM Breakdown Accounts AUM ($B)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 1 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 3 0.2
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 0 0.0
Total 4 0.2
By Discretionary
Discretionary 4 0.2
Non-Discretionary 0 0.0
Total 4 0.2
By Non-United States Persons
Non-United States Persons 0.0
United States Persons 0.2
Total 4 0.2
Form D Directors Role # Filings # Firms 2011 - 2026
Michael Treisman Director, Executive Officer 57 6
Kathleen Rockey Executive Officer 69 5
Andrew Viens Director, Executive Officer 60 5
Sean Doherty Executive Officer 41 5
Michael Goss Executive Officer 26 5
Sally Dornaus Executive Officer 69 4
Mark Moore Executive Officer 32 4
Ranesh Ramanathan Director, Executive Officer 33 3
Adam Koppel Executive Officer 23 3
Colin Campbell Executive Officer 17 3
View All
EDGAR Form CIK 2011 - 2026
13F-HR [0001156175]
3 [0001156175]
4 [0001156175]
5 [0001156175]
SC 13G [0001156175]
13F-HR [0001962552]
Form 13D/13G Filer Form 13D/13G Subject Filed
Bain Capital Public Equity Management LLC Immune Design Corp [2017-10-06]
Bain Capital Public Equity Management LLC Mulesoft Inc [2017-03-30]
Brookside Capital Management LLC Concert Pharmaceuticals Inc [2014-02-28]
Brookside Capital Management LLC Dicerna Pharmaceuticals Inc [2014-02-10]
Brookside Capital Management LLC RingCentral Inc [2014-02-07]
Brookside Capital Management LLC RingCentral Inc [2014-02-07]
Firm Profile (Form ADV)
Discretionary AUM$10.5B
ServesInstitutional
Fund TypesHedge Fund
LEI6UYOOZUIKHTN7U75ZV92
Form 3/4/5 Subject 2011 - 2026
Brookside Capital Partners Fund LP
Mulesoft Inc
Brookside Capital Management LLC
Brookside Capital Trading Fund LP
Radius Health Inc
Brookside Capital Investors L P
Dicerna Pharmaceuticals Inc
Brookside Capital Investors II LP
Concert Pharmaceuticals Inc
Idenix Pharmaceuticals Inc
View All
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Mulesoft Inc MULE
Class A Common Stock
2017-04-04 Sell 10,855 $23.85 258,892
Mulesoft Inc MULE
Class A Common Stock
2017-03-17 Buy 500,000 $17.00 8,500,000
Mulesoft Inc MULE
Class A Common Stock
2017-03-17 Buy 203,082 $25.06 5,089,235
Mulesoft Inc MULE
Class B Common Stock · derivative
2017-03-17 Conversion 890,689
Mulesoft Inc MULE
Series G Convertible Preferred Stock · derivative
2017-03-17 Conversion 890,689
Radius Health Inc NONE
Common Stock
2014-06-05 Buy 500,000 $8.00 4,000,000
Radius Health Inc NONE
Common Stock Warrants · derivative
2014-03-28 Buy 67,160 $6.14 412,362
Radius Health Inc NONE
Series B-2 Convertible Preferred Stock · derivative
2014-03-28 Buy 26,684 $61.42 1,638,931
Dicerna Pharmaceuticals Inc DRNA
Common Stock
2014-03-18 Sell 14,937 $38.62 576,867
Dicerna Pharmaceuticals Inc DRNA
Common Stock
2014-03-18 Sell 250,000 $37.75 9,437,500
Dicerna Pharmaceuticals Inc DRNA
Common Stock
2014-03-17 Sell 9,301 $36.50 339,486
Dicerna Pharmaceuticals Inc DRNA
Common Stock
2014-03-14 Sell 50,400 $35.33 1,780,632
Dicerna Pharmaceuticals Inc DRNA
Common Stock
2014-03-14 Sell 200,000 $35.50 7,100,000
Dicerna Pharmaceuticals Inc DRNA
Common Stock
2014-03-12 Sell 1,500 $37.77 56,655
Dicerna Pharmaceuticals Inc DRNA
Common Stock
2014-03-11 Sell 2,900 $38.37 111,273
Dicerna Pharmaceuticals Inc DRNA
Common Stock
2014-03-11 Sell 257,100 $38.00 9,769,800
Concert Pharmaceuticals Inc CNCE
SERIES B CONVERTIBLE PREFERRED STOCK · derivative
2014-02-19 Conversion 4,300,000 $0.00
Concert Pharmaceuticals Inc CNCE
COMMON STOCK
2014-02-19 Buy 350,000 $14.00 4,900,000
Concert Pharmaceuticals Inc CNCE
COMMON STOCK
2014-02-19 Conversion 761,062
Concert Pharmaceuticals Inc CNCE
SERIES C CONVERTIBLE PREFERRED STOCK · derivative
2014-02-19 Conversion 2,000,000 $0.00
showing 20 of 27 most recent transactions
Related Firms State AUM
Bain Capital Private Equity LP
MA 96.43 B
Bain Capital Credit LP
MA 76.30 B
Bain Capital Real Estate LP
MA 9,995.4 M
Bain Capital Ventures LP
MA 9,837.9 M
BCSF Advisors LP
MA 3,647.4 M
Bain Capital Partnership Strategies LP
MA 1,652.2 M
Bain Capital Public Equity LP
MA 242.2 M
Bain Capital Credit CLO Advisors LP
MA
Comparable Firms State AUM
Metronome Capital LLP
244.9 M
Kultura Capital Management LP
UT 244.7 M
Bandera Partners LLC
NY 244.1 M
ShoreVest Partners Ltd
244.0 M
Little Harbor Advisors LLC
MA 242.6 M
DFN Management LLC
FL 241.4 M
Tenere Capital LLC
NY 241.1 M
English Capital Management LLC
MI 241.1 M
Armatus Capital Management LLC
241.0 M
Clearfield Capital Management LP
NY 240.2 M
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com